top of page
  • PR & Digital Team

Milestone meeting with Reliance Life Sciences at our Dubai office

Updated: Jan 21, 2022

Today TheSAY was elated to have delegates from Reliance Life Sciences who have the highest number of biosimilars under development globally.

We held a productive discussion around business expansion in the CIS & African markets and creating a detailed plan for future vaccine projects with Reliance.

In attendance were, KV Subramaniam (CEO), KV Balasubramaniam (Advisor - vaccines), Muthukrishnan R (Regional Head- ME & Africa) & Sivaraman Vasudevan (Vice President- International Business) from Reliance Life Sciences, along with our Dr. Noushad Abdurahiman M.D.(CEO), Balaji Anbalagan (Pharma Director)

27 views0 comments


bottom of page